Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2012 2
2018 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Editorial of the Special Issue: Antisense Therapies.
Popplewell LJ. Popplewell LJ. Biomedicines. 2018 Sep 27;6(4):95. doi: 10.3390/biomedicines6040095. Biomedicines. 2018. PMID: 30262783 Free PMC article. No abstract available.
Targeting TGFβ Signaling to Address Fibrosis Using Antisense Oligonucleotides.
March JT, Golshirazi G, Cernisova V, Carr H, Leong Y, Lu-Nguyen N, Popplewell LJ. March JT, et al. Among authors: popplewell lj. Biomedicines. 2018 Jun 25;6(3):74. doi: 10.3390/biomedicines6030074. Biomedicines. 2018. PMID: 29941814 Free PMC article. Review.
Optimizing antisense oligonucleotides using phosphorodiamidate morpholino oligomers.
Popplewell LJ, Malerba A, Dickson G. Popplewell LJ, et al. Methods Mol Biol. 2012;867:143-67. doi: 10.1007/978-1-61779-767-5_10. Methods Mol Biol. 2012. PMID: 22454060
Novel cationic carotenoid lipids as delivery vectors of antisense oligonucleotides for exon skipping in Duchenne muscular dystrophy.
Popplewell LJ, Abu-Dayya A, Khanna T, Flinterman M, Abdul Khalique N, Raju L, Øpstad CL, Sliwka HR, Partali V, Dickson G, Pungente MD. Popplewell LJ, et al. Molecules. 2012 Jan 24;17(2):1138-48. doi: 10.3390/molecules17021138. Molecules. 2012. PMID: 22274137 Free PMC article.
Bioinformatic and functional optimization of antisense phosphorodiamidate morpholino oligomers (PMOs) for therapeutic modulation of RNA splicing in muscle.
Popplewell LJ, Graham IR, Malerba A, Dickson G. Popplewell LJ, et al. Methods Mol Biol. 2011;709:153-78. doi: 10.1007/978-1-61737-982-6_10. Methods Mol Biol. 2011. PMID: 21194027
Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials.
Popplewell LJ, Adkin C, Arechavala-Gomeza V, Aartsma-Rus A, de Winter CL, Wilton SD, Morgan JE, Muntoni F, Graham IR, Dickson G. Popplewell LJ, et al. Neuromuscul Disord. 2010 Feb;20(2):102-10. doi: 10.1016/j.nmd.2009.10.013. Epub 2010 Jan 15. Neuromuscul Disord. 2010. PMID: 20079639
Design of phosphorodiamidate morpholino oligomers (PMOs) for the induction of exon skipping of the human DMD gene.
Popplewell LJ, Trollet C, Dickson G, Graham IR. Popplewell LJ, et al. Mol Ther. 2009 Mar;17(3):554-61. doi: 10.1038/mt.2008.287. Epub 2009 Jan 13. Mol Ther. 2009. PMID: 19142179 Free PMC article.
Feedback